? Lycopene, the red pigment of the tomato, is a dietary carotenoid and a potent antioxidant that has been associated by prospective and retrospective epidemiological studies with a decreased incidence of prostate cancer in men. Our preliminary clinical studies in men with prostate cancer indicate that oral administration of lycopene elevates serum and prostate lycopene levels and reduces serum prostate specific antigen (PSA). Our preliminary cell culture studies using human prostate cancer cells show that lycopene is absorbed selectively by and inhibits the proliferation of the androgen sensitive prostate cancer cell line LNCaP but not the androgen-insensitive prostate cancer cell lines DU145 and PC-3. We propose to expand upon these cell culture studies by measuring and comparing the rates of lycopene uptake by the androgen-sensitive cell lines LNCaP, PZ-HPV-7, and BPH-1 (which represent human prostate cancer, BPH, and normal epithelial cells, respectively), and the androgen-insensitive prostate cancer cell lines DU145, PC-3, C4-2B, and CWR22Rv1. Whether the rates of lycopene uptake are inversely proportional to inhibition of proliferation in these cells will be determined. In order to clarify the mechanism of action of lycopene as an antiproliferative agent, we will measure the sub-cellular distribution of lycopene and then investigate changes in protein expression both globally and on the sub-cellular level using the ICAT quantitative proteomics methodology. In addition, a lycopene affinity column will be prepared and used to screen lycopene sensitive cells for a lycopene receptor or binding protein which will be identified using mass spectrometry-based proteomics. Lycopene binding to the androgen receptor will also be investigated. Based on our observation that lycopene reduces PSA levels in men with prostate cancer, we will investigate how the intracellular expression and secretion of PSA is altered by prostate cells treated with lycopene in culture; in addition, we will determine whether total PSA and percent-free PSA are altered in the serum of healthy men receiving lycopene supplements. Finally, we will determine the bioavailability and half-life of two potentially therapeutic doses of lycopene, 30 mg per day and 60 mg per day, using stable isotope labeled lycopene and HPLC-tandem mass spectrometry. These human studies will provide vital information for the design of future clinical trials investigating the chemoprevention of prostate cancer by lycopene. ? ? ?

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
5R01CA101052-02
Application #
6761910
Study Section
Special Emphasis Panel (ZCA1-SRRB-U (J1))
Program Officer
Kim, Young Shin
Project Start
2003-06-17
Project End
2008-05-31
Budget Start
2004-09-09
Budget End
2005-05-31
Support Year
2
Fiscal Year
2004
Total Cost
$321,326
Indirect Cost
Name
University of Illinois at Chicago
Department
Pharmacology
Type
Schools of Pharmacy
DUNS #
098987217
City
Chicago
State
IL
Country
United States
Zip Code
60612
Van Loo-Bouwman, Carolien A; Naber, Ton H J; Minekus, Mans et al. (2014) Food matrix effects on bioaccessibility of ?-carotene can be measured in an in vitro gastrointestinal model. J Agric Food Chem 62:950-5
Qiu, Xi; Yuan, Yang; Vaishnav, Avani et al. (2013) Effects of lycopene on protein expression in human primary prostatic epithelial cells. Cancer Prev Res (Phila) 6:419-27
van Breemen, Richard B; Dong, Linlin; Pajkovic, Natasa D (2012) Atmospheric Pressure Chemical Ionization Tandem Mass Spectrometry of Carotenoids. Int J Mass Spectrom 312:163-172
van Breemen, Richard B; Sharifi, Roohollah; Viana, Marlos et al. (2011) Antioxidant effects of lycopene in African American men with prostate cancer or benign prostate hyperplasia: a randomized, controlled trial. Cancer Prev Res (Phila) 4:711-8
Dahl, Jeffrey H; van Breemen, Richard B (2010) Rapid quantitative analysis of 8-iso-prostaglandin-F(2alpha) using liquid chromatography-tandem mass spectrometry and comparison with an enzyme immunoassay method. Anal Biochem 404:211-6
Dong, Linlin; Shion, Henry; Davis, Roderick G et al. (2010) Collision cross-section determination and tandem mass spectrometric analysis of isomeric carotenoids using electrospray ion mobility time-of-flight mass spectrometry. Anal Chem 82:9014-21
Goo, Young Ah; Liu, Alvin Y; Ryu, Soyoung et al. (2009) Identification of secreted glycoproteins of human prostate and bladder stromal cells by comparative quantitative proteomics. Prostate 69:49-61
van Breemen, Richard B; Pajkovic, Natasa (2008) Multitargeted therapy of cancer by lycopene. Cancer Lett 269:339-51
Goo, Young Ah; Li, Zheng; Pajkovic, Natasa et al. (2007) Systematic investigation of lycopene effects in LNCaP cells by use of novel large-scale proteomic analysis software. Proteomics Clin Appl 1:513-523
Zhu, Dongwei; Wang, Yan; Pang, Yan et al. (2006) Quantitative analyses of beta-carotene and retinol in serum and feces in support of clinical bioavailability studies. Rapid Commun Mass Spectrom 20:2427-32

Showing the most recent 10 out of 12 publications